Matthew Winter

Has grant

Senior Research Fellow

University of Exeter
Country flagUnited Kingdom
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Recent Grants

Grant: Close

An alternative approach for assessing drug-induced seizures, using non-protected larval zebrafish

Open Date: 2018-01-01

Close Date: 2021-01-01

Grant: Close

Advancing mechanistic understaining of glucocorticoid effects in fish

Open Date: 2018-01-01

Close Date: 2022-01-01

Grant: Close

Functional live brain imaging in zebrafish for mechanism–specific detection of drug-induced seizures

Open Date: 2018-01-01

Close Date: 2019-01-01

Grant: Close

Integrated health effects analysis of antidepressants inhibiting serotonin and/or norepinephrine reuptake using zebrafish models

Open Date: 2017-01-01

Close Date: 2020-01-01

Grant: Close

Zebrafish as a model for kidney podocyte assessment

Open Date: 2014-01-01

Close Date: 2015-01-01

Articles (2)

Establishing anaesthesia for ensuring both animal welfare and compatibility with protocols required for different areas of scientific research is vital. Zebrafish ( Danio rerio ) are one of the most used animal models in research; however, little is known about the appropriateness of anaesthetic used for this species, especially for embryo-larval life stages. Using a combination of whole-brain functional imaging, quantification of cardiovascular performance, and behaviour, we explore the efficacy and tolerability of six widely used fish anaesthetics (2-phenoxyethanol, benzocaine, etomidate, MS222, isoeugenol and quinaldine sulfate) in larval zebrafish. We show that MS222 and quinaldine sulfate are the most suitable for achieving deep anaesthesia, while etomidate is better suited for studies focused on the cardiovascular system. Only quinaldine sulfate was found to be aversive. Our findings aid researchers for selecting the most suitable anaesthetic compounds and concentrations for their specific research goals, and the refinement of studies using anaesthesia in larval zebrafish.

Year:

2025

The International Academy of Toxicologic Pathology (IATP) Satellite Symposium on “New Approach Methodologies (NAMs) for Neurotoxicity Assessment and Regulatory Perspectives,” organized in Spain, addressed the growing need for improved assessment of neurotoxicity. Traditional neurotoxicity assessment using in vivo animal studies are impractical for testing the substantial number of environmental chemicals that currently lack data and in the early detection of neuro-related adverse reactions in drug discovery. The NAMs, including human in vitro assays and small model organisms, have been developed for faster and cost-effective assessment of neurotoxic potential. While NAMs offer improved practicality, utility, and valuable mechanistic insights, their integration into regulatory decision-making requires robust scientific validation and technical characterization. Confidence in and regulatory application of NAMs data can be supported by mapping cellular outcomes to neuropathological findings in mammals, including humans, through the Adverse Outcome Pathway (AOP) framework, and the Integrated Approach to Testing and Assessment (IATA). Case studies presented demonstrated the application of NAMs in chemical and drug safety evaluations, focusing on developmental neurotoxicity (DNT), Parkinson’s disease, and drug-induced seizures. In conjunction with in vivo toxicology studies, NAMs represent a significant step toward advancing chemical and drug toxicity assessment via hazard identification and drug screening safety assessments.

Year:

2025

Collaborators (3)

Lynne Sneddon

University of Gothenburg

SWEDEN
View details

Tetsuhiro Kudoh

Senior Lecturer

University of Exeter

UNITED KINGDOM
View details

Sylvia Dimitriadou

University of Exeter

UNITED KINGDOM
View details